FEMOSTON

This brand name is authorized in Australia, Austria, Brazil, Croatia, Cyprus, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, South Africa, UK.

Active ingredients

The drug FEMOSTON contains a combination of these active pharmaceutical ingredients (APIs):

1	Estradiol UNII CXY7B3Q98Z - ESTRADIOL HEMIHYDRATE
	Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estradiol
2	Dehydroprogesterone UNII 90I02KLE8K - DYDROGESTERONE
	Dydrogesterone is an orally-active progestogen having an activity comparable to parenterally administered progesterone.
	Read more about Dehydroprogesterone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FEMOSTON Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03FA14	Dydrogesterone and estrogen	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03F Progestogens and estrogens in combination → G03FA Progestogens and estrogens, fixed combinations
Discover more medicines within G03FA14
G03FB08	Dydrogesterone and estrogen	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03F Progestogens and estrogens in combination → G03FB Progestogens and estrogens, sequential preparations
Discover more medicines within G03FB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10142T, 10146B, 8244X
BR	Câmara de Regulação do Mercado de Medicamentos	500214100032317, 500214100032417
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00018419, 00056495, 00608925, 00608931, 00988709, 01020358, 01086133, 01086156, 01214789, 01214795, 03913439, 05023709, 06474704, 06901750, 06901767, 08603198, 08603206, 08737869, 09082494, 09082502, 10402797, 12381786, 12381792, 12415108, 16890562, 17165018, 17562972
EE	Ravimiamet	1013803, 1082450, 1082528, 1082539, 1082540, 1375332, 1375343, 1375354
FI	Lääkealan turvallisuus- ja kehittämiskeskus	004579, 024315, 058545, 402343
GB	Medicines & Healthcare Products Regulatory Agency	142334, 161765, 161784, 182943, 185788, 186492, 212594, 25872, 33482, 33502, 374510, 376371, 381337, 390892, 396482, 396484, 398374
HK	Department of Health Drug Office	40939, 49421, 49643
HR	Agencija za lijekove i medicinske proizvode	HR-H-056380101, HR-H-361841297, HR-H-663625220, HR-H-831928897
IE	Health Products Regulatory Authority	24143, 24164, 34236, 36925
IL	מִשְׂרַד הַבְּרִיאוּת	8388, 8659, 8660
LT	Valstybinė vaistų kontrolės tarnyba	1003542, 1003544, 1015309, 1015311, 1055927, 1055928, 1055929
MT	Medicines Authority	MA1507/01101, MA1507/01102, MA1507/01103, MA1507/01104, PI1438/03401A, PI1438/03402A, PI1438/03403A, PI1438/03404A
NL	Z-Index G-Standaard, PRK	101575, 104639, 111864, 96393
PL	Rejestru Produktów Leczniczych	100111541, 100124147, 100169210, 100211930, 100231653, 100344943, 100349567, 100355160, 100366531, 100402451, 100413466, 100437076, 100455780, 100460842, 100462195, 100464909, 100466910
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69163001, W69163002
SG	Health Sciences Authority	09530P, 11896P, 12121P
ZA	Health Products Regulatory Authority	30/21.8.2/0256, 36/21.8.2/0329, 36/21.8.2/0330